Catalyst Pharmaceuticals (NASDAQ: CPRX) announces its next round of earnings this Monday, August 10. Here is Benzinga's everything-that-matters guide for this Monday's Q2 earnings announcement.

Earnings and Revenue

Wall Street analysts see Catalyst Pharmaceuticals reporting earnings of $0.08 per share on sales of $29.48 million. In the same quarter last year, Catalyst Pharmaceuticals reported earnings per share of $0.1 on sales of $28.84 million. If the company were to report in-line earnings when it publishes results Monday, earnings would be down 20.0%. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:

Stock Performance

Over the last 52-week period, shares are down 17.68%. Given that these returns are generally negative, long-term shareholders won't be happy going into this earnings release.